HighTower Advisors
LONA

HighTower Advisors’s LeonaBio Inc LONA Stock Holding History

HighTower Advisors’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,270
Closed -$3.83K – 3829
2025
Q2 		$3.83K Hold
1,270
– – ﹤0.01% 3691
2025
Q1 		$3.62K Hold
1,270
– – ﹤0.01% 3599
2024
Q4 		$7.45K Buy
1,270
+23
+2% +$130 ﹤0.01% 3602
2024
Q3 		$6K Hold
1,247
– – ﹤0.01% 3581
2024
Q2 		$33K Hold
1,247
– – ﹤0.01% 3355
2024
Q1 		$34K Hold
1,247
– – ﹤0.01% 3300
2023
Q4 		$30K Sell
1,247
-7
-0.6% -$124 ﹤0.01% 3361
2023
Q3 		$26K Hold
1,254
– – ﹤0.01% 3303
2023
Q2 		$37K Buy
+1,254
New +$35.7K ﹤0.01% 3196

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return

HighTower Advisors's LONA Position: Q3 2025 in Review

HighTower Advisors sold out of LeonaBio Inc (LONA) in Q3 2025, closing a stake of 1,270 shares — an estimated $3.83K sold.

HighTower Advisors first reported a position in LONA in Q2 2023 and held it in 9 quarters. The position peaked at $37K in Q2 2023. 34 funds tracked by Wall St. Rank hold LONA as of Q3 2025.

  • HighTower Advisors reported no remaining LeonaBio Inc position as of Q3 2025 after selling out during the quarter.
  • HighTower Advisors sold 1,270 LeonaBio Inc shares in Q3 2025, an estimated $3.83K.
  • HighTower Advisors first reported a position in LeonaBio Inc in Q2 2023 and held it in 9 quarters.
  • HighTower Advisors's LeonaBio Inc position peaked at $37K in Q2 2023.
  • 34 funds tracked by Wall St. Rank held LeonaBio Inc as of Q3 2025.

Based on HighTower Advisors's 13F filing for Q3 2025, filed 7 Nov 2025.